Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumor, Adult × Interleukin-2 × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 7 Neoplasms 6 Melanoma 6 Colorectal Neoplasms 6 Lymphoma, Non-Hodgkin 5 Carcinoma, Non-Small-Cell Lung 5 Uterine Cervical Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma 4 Carcinoma, Merkel Cell 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Head and Neck Neoplasms 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Breast Neoplasms 2 Anus Neoplasms 2

Interventions

pembrolizumab 5 Proton Therapy 3 spartalizumab 2 Paclitaxel 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 toripalimab 1 sotorasib 1 peposertib 1 necitumumab 1 leronlimab 1 abemaciclib 1 Valganciclovir 1 Trastuzumab 1 Therapeutics 1 Radiotherapy 1 PankoMab-GEX 1 Panitumumab 1 MEK inhibitor I 1 Jupiter 1 Ipilimumab 1 Interleukin-2 1 GAT 1 Fulvestrant 1 FCN-437c 1 EBI-005 1 Docetaxel 1 Catalytic Domain 1 Carboplatin 1 CS-1003 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05307874 2025-12-24

EVICTION-2

ImCheck Therapeutics

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡